[Managements and Prognostic Analyses in Patients with Invasive Fungal Rhinosinusitis].
W Zhou,Q Liu,W D Zhao,H P Yu,X C Sun,J,Z F Liu,H Y Li,C Q Zheng,S Y Wang,D H Wang
DOI: https://doi.org/10.3760/cma.j.issn.1673-0860.2016.08.002
2016-01-01
Abstract:OBJECTIVE To evaluate the survival outcomes of invasive fungal rhinosinusitis by analyzing the clinical features. METHODS A retrospective analysis was performed for cases of invasive fungal sinusitis proved by histological analysis between March 2006 and November 2015. All relevant factors including interval from the onset of symptoms to initiation of diagnosis, clinical characteristics, features of CT and MRI, treatment and prognosis were collected. A total of 18 patients (10 males; 8 females) were identified. The median age was 54 years old. Three patients suffered from acute invasive fungal sinusitis, while the other 15 suffered from chronic invasive fungal sinusitis. RESULTS The mean duration between onset of symptoms and diagnosis was 5 months. The most common symptom was headache (10/18), followed by visual disturbance (7/18), nasal obstruction (4/18), facial numbness and pain (2/18) and diplopia(2/18). Two patients had diabetes mellitus; one patient had ankylosing spondylitis receiving immunosuppressive drugs treatment for one year. Four patients had the disease confined in the sinus. Complications of this disease included orbital apex involvement in 6 patients, intraorbital and optic nerve involvement in 3 patients, cavernous sinus involvement in 5 patients, pterygopalatine fossa and infratemporal fossa involvement in 5 patients, intracranial extension involvement in 3 patients. Fungal species included aspergillus (15 cases) and mucor (3 cases). Seventeen patients received intravenous antifungal therapy after surgery. The duration of follow-up ranged from 1 to 60 months. Two patients reoccurred and one patient died of the disease. CONCLUSION Endoscopic debridement combined with intravenous antifungals is efficacious in the management of invasive fungal sinusitis.